Disorders and Conditions

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

The Height Problem No One Wants to Talk About

Pat Farrell PhD - August 19, 2025

As you enter a job interview you discover through instinct that the interviewer has already formed impressions about your leadership potential based solely on your...

Feeling Anxious or Blue? Might Be Your Diet

Michael Hunter, MD - September 12, 2022

COULD ULTRA-PROCESSED FOODS INFLUENCE YOUR MOOD? The answer may be yes.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

SUICIDE: IS AI RESPONSIBLE?

Kill the Oceans and Destroy Your Health Slowly

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Mental Health Secrets Are Being Unraveled, and Inflammation Is the Culprit

LATEST

TRENDING

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

Your Jewish Friends Are Not Alright

From Skinner’s Operant Conditioning to Artificial Intelligence’s Algorithms

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Big Boys Do Cry, and It’s a Normal Reaction, Not Weakness

Cher’s Severe, Hidden Disorder Chipped Away at Her Self-Esteem

Your Brain Benefits From Walking

How To Spot Sensory “Masking” In Autism Spectrum Disorder

FDA Approval of New Drug for Alzheimer’s Offers Hope

Christmas in a Psychiatric Hospital

EDITORS CHOICE

Smoke, Dip, or Pouch It and Suffer the Horrific Consequences?

FDA Approval of New Drug for Alzheimer’s Offers Hope

The Height Problem No One Wants to Talk About

Feeling Anxious or Blue? Might Be Your Diet

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories